Graft-Versus-Host Disease (GVHD) Treatments
CancerLeukemia
Explore This Topic

Graft-Versus-Host Disease (GVHD) Treatment: Medication, Lifestyle Changes, and More

Graft-Versus-Host Disease (GVHD) Treatment: Medication, Lifestyle Changes, and More
Everyday Health
By
Published on May 2, 2025
by
Many treatments are available for graft-versus-host disease (GVHD), a severe complication that can occur after a transplant (typically after a bone marrow or stem cell transplant).

GVHD occurs when immune cells from the donor’s graft recognize the recipient's tissues as foreign and start to attack them. This immune attack can affect the tissues in every organ, including the skin, intestines, liver, and lungs.

Experts typically categorize GVHD into two types — acute or chronic — depending on when the symptoms started, how severe they are, and how long they last. Before starting a new treatment or combining treatments, speak to your healthcare professional to discuss which treatments are best for you.

Acute GVHD Treatments

A variety of medications are used to treat acute GVHD. Depending on the severity of GVHD, your doctor may escalate treatment.

Corticosteroids

Doctors typically recommend corticosteroids as an initial therapy or first-line treatment for both acute and chronic GVHD.

Corticosteroids suppress the immune system (including the new immune cells acquired from the graft) and stop it from attacking your tissues.

 Your doctor may prescribe topical corticosteroids (applied on the skin), especially as a first option, or they may prescribe systemic steroids that affect your entire body (usually taken in pill form) for more severe cases of GVHD.

Common corticosteroids used in GVHD include:

  • beclomethasone (Beconase, Clenil, Qvar)
  • budesonide (Entocort, Pulmicort, Rhinocort)
  • methylprednisolone (Depo-Medrol, Medrol, Solu-Medrol)
  • prednisolone (Millipred, Orapred, Prelone)
Budesonide and beclomethasone tend to be used when GVHD is affecting the gastrointestinal tract.

Corticosteroids also come with significant side effects. The same mechanism that enables them to treat GVHD causes a weakened immune system (immunosuppression), which can lead to an increased risk of infections, high blood sugar levels (hyperglycemia), and frail bone (osteopenia).

Calcineurin Inhibitors

Calcineurin inhibitors stop or inhibit a chemical called calcineurin, which, in turn, blocks the action of T-cells, a type of immune cell.

 T cells are key players in the immune attack that characterizes GVHD, so blocking them helps treat the condition.

Calcineurin inhibitors are often used in combination with steroids to help control GVHD, or when the illness hasn’t responded to corticosteroids alone.

 They can also be given topically or systemically.

Calcineurin inhibitors commonly used to treat GVHD include:

Calcineurin inhibitors are also immunosuppressants, like steroids. They have similar side effects that result from weakening the immune system — a higher risk of infection and illness. Other side effects can include liver toxicity, high blood pressure, and gastrointestinal problems.

Monoclonal Antibodies

Monoclonal antibodies target certain proteins on the surface of cells and destroy or block them to reduce the immune system’s attack on healthy tissue. Monoclonal antibodies are usually administered through an IV.

 Common monoclonal antibodies for GVHD include:

Monoclonal antibodies come with side effects and risks, such as infusion reactions (fever, chills, low blood pressure), a heightened risk of infection, and a higher risk in the long-term of developing secondary cancers.

Other Immunosuppressants

Doctors often treat GVHD with other drugs that dampen the immune system, such as:

These are usually taken by mouth, and may be used on their own or in combination with other medications.

 Side effects vary, but overall they include diarrhea, sickness, and a higher risk of infections.

13 of the Best Foods for Chronic GVHD

Easy to digest and packed with nutrients to aid recovery and manage symptoms, these 13 foods are some of the best for managing GVHD.
13 of the Best Foods for Chronic GVHD

Next up video playing in 10 seconds

Chronic GVHD Treatments

Many of the treatments mentioned above are also used to treat severe or chronic GVHD. But, in cases where GVHD doesn’t improve or lasts for a long time, there are other treatment options.

Anti-Thymocyte Globulin (ATG)

Anti-thymocyte globulin (ATG) may help suppress the immune system in chronic GVHD cases. ATG is typically given through an IV infusion, and it works by killing off T cells.

 Stopping the activity of these T cells helps control GVHD symptoms.

Side effects of ATG therapy include fever, a rash, nausea and vomiting, diarrhea, and headaches.

TKI Inhibitors

Tyrosine kinase inhibitors (TKIs) are targeted drug therapies that stop immune cells from growing and dividing. Common TKIs used for chronic GVHD include:

  • ibrutinib (Imbruvica), an oral drug that should be taken with caution due to its possible serious side effects in people with certain medical conditions, such as recurring infections, diarrhea, heart problems, or for those who are taking anticoagulants and are at risk of bleeding

  • imatinib (Gleevec), a drug commonly prescribed when chronic GVHD affects the skin or the lungs

TNF Inhibitors

TNF inhibitors block a chemical called tumor necrosis factor (TNF) from damaging tissue.

 TNF inhibitors for chronic GVHD include:

These drugs are particularly suitable for when GVHD affects the gastrointestinal tract, and can be added to a course of steroids when GVHD is chronic or severe.

 They have many potential side effects, such as infection or fever, so they must be taken with caution, after discussing the potential risks with your doctor.

Other FDA-Approved Drugs for Chronic GVHD

Other drugs that the U.S. Food and Drug Administration (FDA) has approved for treating chronic GVHD or GVHD that doesn’t respond to steroids include:

  • axatilimab-csfr (Niktimvo), a drug available by IV infusion. The most common side effects include infection, joint and muscle pain, nausea, headache, fatigue, diarrhea, cough, and shortness of breath.

  • belumosudil (Rezurock), a type of drug called a ROCK2-inhibitor that is taken orally.

     Side effects include infections, lack of energy, nausea, and diarrhea.

  • remestemcel-L-rknd (Ryoncil), usually prescribed for chronic GVHD in children and teens

  • ruxolitinib (Jakafi), a JAK-inhibitor that is also approved for chronic GVHD.

     Low levels of platelets and increased infection risk are two of its most common side effects.

There are new drugs being discovered and tested for treating GVHD. Speak to your doctor or search CinicalTrials.gov to learn more about other possible treatments.

Light Therapy (Photopheresis)

If your condition doesn’t respond to other treatments, your doctor may recommend a procedure called extracorporeal photopheresis, or light therapy.

Photopheresis may improve chronic GVHD of the lungs, skin, liver, and mouth. It’s a complex process that takes several months to show improvement.

During photopheresis, you’re connected to a machine through an IV drip. The machine removes white blood cells from your blood, treats them with a special chemical, and exposes them to ultraviolet (UV) light. The light activates the chemical, which then destroys the abnormal white blood cells. Then, the treated white blood cells are returned back to you through the drip in your vein.

The procedure may cause weakness and dizziness, and you may need a central line — a thin tube inserted into one of your large veins — to draw blood for this therapy.

Lifestyle Changes for GVHD

Joseph Uberti, MD, PhD, a hematologist, medical oncologist, and the leader of the Bone Marrow and Stem Cell Transplant Multidisciplinary Team at the Karmanos Cancer Institute in Detroit, says there are important lifestyle changes that people must make to help them recover from a transplant.

“First, the patient has to stop smoking completely. Pulmonary toxicity is very difficult after a transplant, and any history of smoking worsens that.”

“Secondly, patients have to maintain good nutritional status,” Dr. Uberti says. “This is often difficult with the gastrointestinal problems patients have after transplant.”

The National Marrow Donor Program (NMDP) recommends these lifestyle changes:

  • Eat a healthy diet with sufficient sources of calcium, and cut back on salt and sugar.
  • Keep regular doctor’s appointments to the ophthalmologist, dentist, and dermatologist.
  • Wear hats and sunscreen to protect your skin from the sun.
  • Drink plenty of water.
  • Exercise regularly.
  • Avoid excessive alcohol use.

Rehabilitation and Therapy for GVHD

“Physical and occupational therapy are vital for recovery post-transplant,” says Uberti. “Extended hospitalization for transplants often results in severe weakness in patients, which is why it’s important to try to improve this on discharge.”

“Seek guidance from your doctor on how to incorporate rehab therapies into your recovery,” Uberti adds. “Even small increases in physical activity lead to tremendous benefits,” he says.

Complementary Therapies for GVHD

Your doctor may recommend some supportive therapies to help along your treatment and recovery. These may include:

  • Total parenteral nutrition (TPN), also called intravenous feeding, for cases where GVHD is affecting your bowels; TPN can help you maintain your strength and prevent malnutrition
  • Antimicrobial medications to protect you from bacterial, viral, fungal, or parasitic infections, which tend to occur as side effects of immunosuppressants
  • Bone-strengthening drugs to prevent bone loss, which can occur as a side effect of steroids

Pain Management

“Multiple strategies may be used to treat and prevent some of the painful side effects of transplants,” says Uberti. “This is often a long-lasting treatment requirement.”

For example, exercising and stretching regularly, especially alongside rehabilitation therapy and support, can help reduce pain and fatigue when you’re living with GVHD.

Mental Health Treatment

It's not uncommon to experience anxiety or depression when you have GVHD — especially chronic GVHD — and treatment for these conditions can be greatly beneficial.

Speak to your doctor if you’re struggling to cope with your condition. Turn to support groups, your friends and family, or opt for a counselor who can help you navigate the challenges of this condition.

The Takeaway

  • There are many treatments available for both acute and chronic GVHD.
  • Corticosteroids are the most commonly prescribed initial treatment.
  • If steroids don’t work, there is a wide array of immunosuppressants available that can dampen your immune system’s reaction, helping to ease GVHD symptoms.
  • GVHD treatments come with a range of side effects, so they must be considered with caution. You and your doctor will discuss the best treatment course for you, taking into account the benefits and risks of each therapy.
  • There are many new therapies that emerge every day for GVHD, and countless others that are being tested. Speak to your doctor if you’re interested in joining a clinical trial for a new medication.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Vaillant AAJ et al. Graft-Versus-Host Disease. StatPearls. June 7, 2024.
  2. Flinn AM et al. Recent Advances in Graft-Versus-Host Disease. Faculty Reviews. March 6, 2023.
  3. Garnett C et al. Treatment and Management of Graft-Versus-Host Disease: Improving Response and Survival. Therapeutic Advances in Hematology. December 2013.
  4. Penack O et al. Prophylaxis and Management of Graft-Versus-Host Disease After Stem-Cell Transplantation for Hematological Malignancies: Updated Consensus Recommendations of the European Society for Blood and Marrow Transplantation. The Lancet Haematology. February 2024.
  5. Omar A et al. Calcineurin Inhibitors. StatPearls. November 12, 2023.
  6. Drugs Used for Treating GvHD. Cancer Research UK. March 8, 2022.
  7. Huang S et al. Recent Advances and Research Progress Regarding Monoclonal Antibodies for Chronic Graft-Versus-Host Disease. Heliyon. October 15, 2024.
  8. Graft-Versus-Host Disease (Fact Sheet No. 32). The Leukemia and Lymphoma Society.
  9. Azathioprine. MedlinePlus. December 15, 2023.
  10. Immunosuppressive Therapy. Aplastic Anemia and MDS International Foundation (AAMDS). 2024.
  11. Drugs Used for Treating GHD. Cancer Research UK. March 8, 2022.
  12. FDA Approves Axatilimab-csfr for Chronic Graft-Versus-Host Disease. U.S. Food and Drug Administration. August 14, 2024.
  13. Jaber N. FDA Approves Belumosudil to Treat Chronic Graft-Versus-Host Disease. National Cancer Institute. August 18, 2021.
  14. Fast Facts: Living With Chronic GVHD. National Marrow Donor Program (NMDP). April 2024.
Meet Our Experts
See Our Editorial PolicyMeet Our Health Expert Network
walter-tsang-bio

Walter Tsang, MD

Medical Reviewer
Castle Connolly Top Doctor, Member of American College of Lifestyle Medicine
Walter Tsang, MD, is a board-certified medical oncologist, hematologist, and lifestyle medicine specialist. Inspired by the ancient Eastern philosophy of yang sheng ("nourishing life"), Dr. Tsang has developed a unique whole-person oncology approach that tailors cancer care and lifestyle recommendations to each patients’ biopsychosocial-spiritual circumstances. He partners with patients on their cancer journeys, emphasizing empowerment, prevention, holistic wellness, quality of life, supportive care, and realistic goals and expectations. This practice model improves clinical outcomes and reduces costs for both patients and the healthcare system. 

Outside of his busy clinical practice, Tsang has taught various courses at UCLA Center for East West Medicine, Loma Linda University, and California University of Science and Medicine. He is passionate about health education and started an online seminar program to teach cancer survivors about nutrition, exercise, stress management, sleep health, and complementary healing methods. Over the years, he has given many presentations on integrative oncology and lifestyle medicine at community events. In addition, he was the founding co-chair of a lifestyle medicine cancer interest group, which promoted integrative medicine education and collaborations among oncology professionals.

Tsang is an active member of American Society of Clinical Oncology, Society for Integrative Oncology, and American College of Lifestyle Medicine. He currently practices at several locations in Southern California. His goal is to transform cancer care in the community, making it more integrative, person-centered, cost-effective and sustainable for the future.
See full bio

Ana Sandoiu

Author

Ana is a freelance medical copywriter, editor, and health journalist with a decade of experience in content creation. She loves to dive deep into the research and emerge with engaging and informative content everyone can understand. Her strength is combining scientific rigor with empathy and sensitivity, using conscious, people-first language without compromising accuracy.

Previously, she worked as a news editor for Medical News Today and Healthline Media. Her work as a health journalist has reached millions of readers, and her in-depth reporting has been cited in multiple peer-reviewed journals. As a medical copywriter, Ana has worked with award-winning digital agencies to implement marketing strategies for high-profile stakeholders. She’s passionate about health equity journalism, having conceived, written, and edited features that expose health disparities related to race, gender, and other social determinants of health.

Outside of work, she loves dancing, taking analog photos, and binge-watching all the RuPaul’s Drag Race franchises.

See full bio
See Our Editorial PolicyMeet Our Health Expert Network